NUOBIKAN's stock plummeted 5.16% during the intraday session, reflecting significant selling pressure.

The decline is attributed to continued profit-taking by investors following the stock's recent inclusion in the Stock Connect program, as the positive catalyst from this event is now considered fully priced in. Additionally, underlying concerns about the company's business quality have persisted, highlighted by a significant mismatch in its 2025 financial results where revenue grew 23.7% year-over-year but net profit attributable to shareholders increased by only 2.1%.

Market skepticism has also not fully dissipated regarding a recent administrative penalty against one of its suppliers, Hengxin Dongfang, for revenue inflation in 2022. Although NUOBIKAN issued a clarification stating it was unaware of the irregularities and that all transactions were legitimate, investor confidence remains under pressure. The stock's low free float of approximately 30 million shares has further amplified price volatility amid the ongoing sell-off.